Microbix Announces Quality Products Distribution Agreement

Appointment of R-Biopharm AG for 11 Countries

MISSISSAUGA, Ontario, May 15, 2020 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix), an award-winning life sciences innovator and exporter, announces the appointment of R-Biopharm AG (R-Biopharm) as distributor of its Quality Assessment Products (QAPs) in eleven (11) countries.

Under an agreement between the parties, R-Biopharm has been appointed as distributor of Microbix’s quality assessment products (QAPs) for Australia, Belgium, Canada, France, Germany, Luxembourg, Netherlands, New Zealand, Norway, Spain, and the United Kingdom. As distributor, R-Biopharm will provide marketing, distribution, and logistical support for Microbix’s QAPs. At present, there are four dozen such QAPs across the PROCEEDx and REDx Controls tradenames – to support whole-process accuracy of tests for bacterial and viral diseases by emulating patient samples while being consistent, non-infectious, stable, and cross-instrument compatible. 

Founded in 1988 and based in Darmstadt, Germany, R-Biopharm is a privately-owned biotech company with over 1,000 employees. R-Biopharm is a leading developer of test solutions for clinical diagnostics and food & feed analysis. R-Biopharm test kits offer high precision and accuracy – key requirements where patient or consumer health is at risk. It operates worldwide and has facilities in 12 countries, with dedicated teams for sales, marketing, field service supporting the clinical diagnostics sector.

R-Biopharm will provide physical distribution, sales and marketing, and technical support for the full line of Microbix QAPs. This will include Microbix’s QAPs to support the accuracy of testing for respiratory viruses such as SARS-CoV-2 (COVID-19), Flu A, Flu B, and RSV, as well as its leading-edge QAPs for high-risk types of HPV and other sexually-transmitted infections. R-Biopharm already services clinical labs conducting such testing throughout the distribution territories and is well-positioned to offer access to the full Microbix QAPs catalogue.

Phil Casselli, SVP of Sales and Business Development of Microbix commented, “We’re very pleased to have R-Biopharm become a distribution partner for our QAPs product lines. As a globally recognized diagnostic test manufacturer, they regularly meet with key personnel in hospitals and clinical labs. Our controls are a perfect complement to their product mix and their field team is well suited to deliver excellent user-training and after sales support for our growing PROCEEDx and REDx Controls product lines.”